Sonographic diagnosis of triplet tubal pregnancy after in vitro fertilization and embryo transfer

Journal of Clinical Ultrasound

Volumn 26, Issue 3, 1998, Pages 159-162

  Tsai, Horng Der ^a   Chang, Chi Chen ^a   Hsieh, Yao Yuan ^a   Chang, Chi Chia ^a   Yang, Tung Chuan ^a   Chen, Chun Mu ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Ectopic pregnancy; Embryo transfer; Hydrosalpinx; In vitro fertilization; Triplet tubal pregnancy; Ultrasonography

Indexed keywords

ADULT; ARTICLE; CASE REPORT; COMORBIDITY; CURETTAGE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FETUS ECHOGRAPHY; HUMAN; HYDROSALPINX; LAPAROSCOPY; MULTIPLE PREGNANCY; SALPINGECTOMY; UTERINE TUBE PREGNANCY;

ADULT; AMNION; ANTIMETABOLITES; CHORION; EMBRYO TRANSFER; FALLOPIAN TUBE DISEASES; FEMALE; FERTILIZATION IN VITRO; GESTATIONAL AGE; HUMANS; LAPAROSCOPY; METHOTREXATE; PREGNANCY; PREGNANCY, MULTIPLE; PREGNANCY, TUBAL; PRENATAL CARE; TRIPLETS; ULTRASONOGRAPHY, PRENATAL;

EID: 0031887763     PISSN: 00912751     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0096(199803/04)26:3<159::AID-JCU9>3.0.CO;2-L     Document Type: Article

References (14)

1. Yamashita T, MacLachlan V, Okamoto S, et al: Predicting pregnancy outcome after in vitro fertilization and embryo transfer using estradiol, progesterone, and human chorionic gonadotropin β-subunit. Fertil Steril 1989;51:304.
2. Tsai HD, Chen CM, Lo HY, et al: Subcutaneous low dose leuprolide acetate depot versus leuprolide acetate for women undergoing ovarian stimulation for in-vitro fertilization. Hum Reprod 1995;10: 2909.
3. Stovall TG, Ling FW: Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol 1993; 168:1759.
4. Marcus SF, Brinsden PR. Analysis of the incidence and risk factors associated with ectopic pregnancy following in-vitro fertilization and embryo transfer. Hum Reprod 1995;10:199.
5. Verhulst G, Camus M, Bollen M, et al: Analysis of the risk factors with regard to the occurrence of ectopic pregnancy after medically assisted procreation. Hum Reprod 1993;8:1284.
6. Hamilton CJCM, Legarth J, Jaroudi KA: Intramural pregnancy after in vitro fertilization and embryo transfer. Fertil Steril 1992;57:215.
7. Nazari A, Askari HA, Check JH, et al: Embryo transfer technique as a cause of ectopic pregnancy in in vitro fertilization. Fertil Steril 1993;60:919.
8. Dubuisson JB, Foulot H, Aubriot FX, et al: Risk factors for ectopic pregnancy in 556 pregnancies after in vitro fertilization: implications for preventive management. Fertil Steril 1991;56:686.
9. Strandell A, Waldenström U, Nilsson L, et al: Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates. Hum Reprod 1994;9:861.
10. Nylund L, Gustafson O, Lindblom B, et al: Placental protein 14 in human in-vitro fertilization early pregnancies. Hum Reprod 1992;7:128.
11. Feichtinger W, Kemeter P: Conservative treatment of ectopic pregnancy by transvaginal aspiration under sonographic control and methotrexate injection. Lancet 1987;1:381.
12. Ménard A, Hauuy JP, Créquat J, et al: Treatment of unruptured tubal pregnancy by local injection of methotrexate under transvaginal sonographic control. Fertil Steril 1990;54:47.
13. Vermesh M: Conservative management of ectopic gestation. Fertil Steril 1989;51:559.
14. Casson PR, Stovall TG: Tubal and ovarian surgery. In: Stovall TG, Ling FW, eds: Atlas of Benign Gynecologic and Obstetric Surgery. St. Louis, Mosby-Wolfe, 1995, p. 72.